Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

7.5K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Proteomic Analysis of Cerebrospinal Fluid From Neurological Patients With and Without Amyotrophic Lateral Sclerosis.

Journal of neurochemistry·2026
Same author

Myosin Post-Translational Modifications Associated With Critical Illness Myopathy.

Acta physiologica (Oxford, England)·2026
Same author

Systems neuroendocrinology in ME/CFS and long COVID: a chronobiological framework for hormone-based research.

Frontiers in neuroendocrinology·2026
Same author

Combatting ventilator induced diaphragm dysfunction with human bone marrow mesenchymal stromal cell-derived extracellular vesicles.

Skeletal muscle·2026
Same author

Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.

Brain : a journal of neurology·2026
Same author

Proteomic signatures in cerebrospinal fluid and their clinical associations in patients with ME/CFS.

Scientific reports·2026
Same journal

Advances in application of microplasmas for non-metallic species analysis by optical spectrometry.

The Analyst·2026
Same journal

Sulfur vacancy-mediated self-photocatalysis-boosted electrochemiluminescence sensing <i>via</i> molecular oxygen activation for sensitive detection of isocarbophos.

The Analyst·2026
Same journal

Analytical challenges in mapping the subcellular metabolome and lipidome.

The Analyst·2026
Same journal

Threshold-guided multiplex PCR-LFA: a step toward UTI pathogen detection.

The Analyst·2026
Same journal

Aptamer-based CRISPR-Cas12a fluorescent biosensors for serum biomarker detection.

The Analyst·2026
Same journal

A two-step centrifugal microfluidic platform for semi-automated IGRA detection of tuberculosis based on chemiluminescence.

The Analyst·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

12.4K

Recent developments in proteomic methods and disease biomarkers.

Nina Bergman1, Jonas Bergquist

  • 1Analytical Chemistry, BMC, Department of Chemistry, Uppsala University, Sweden. jonas.bergquist@kemi.uu.se.

The Analyst
|July 1, 2014
PubMed
Summary
This summary is machine-generated.

Discovering novel disease biomarkers using proteomic methods is crucial for early disease detection and avoiding invasive treatments. This review highlights recent advancements in proteomic techniques for accurate biomarker identification and validation.

More Related Videos

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

11.4K
Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples
14:51

Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples

Published on: November 13, 2021

4.9K

Related Experiment Videos

Last Updated: Apr 27, 2026

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

12.4K
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

11.4K
Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples
14:51

Comprehensive Workflow of Mass Spectrometry-based Shotgun Proteomics of Tissue Samples

Published on: November 13, 2021

4.9K

Area of Science:

  • Biomarker discovery
  • Proteomics
  • Disease diagnostics

Background:

  • Proteomic methodologies for biomarker identification are rapidly evolving.
  • Early disease biomarker detection can prevent invasive and costly treatments.
  • Low biomarker concentrations and complex biological matrices pose detection challenges.

Purpose of the Study:

  • To review recent developments in proteomic methodologies for disease biomarker identification and validation.
  • To provide historical context for proteomic biomarker discovery.
  • To address challenges in clinical biomarker screening.

Main Methods:

  • Review of recent literature (last three years) on proteomic techniques.
  • Analysis of historical trends in biomarker discovery.
  • Discussion of challenges in biomarker detection and validation.

Main Results:

  • Significant advancements in proteomic methodologies have occurred.
  • New techniques offer potential for faster and more accurate biomarker detection.
  • Validation of methods for clinical use remains a key challenge.

Conclusions:

  • Continued research in proteomics is essential for improving disease diagnostics.
  • Development of sensitive and specific assays is critical for clinical application.
  • Proteomics holds significant promise for personalized medicine and preventative healthcare.